-
AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort Posted on by TrueParallel in News&Uncategorized
-
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy Posted on by TrueParallel in News&Uncategorized
-
First Participant Randomized in Europe in AskBio Phase 2 Gene Therapy Trial for Congestive Heart Failure Posted on by TrueParallel in News
-
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease Posted on by TrueParallel in News&Uncategorized
-
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 Posted on by TrueParallel in News&Uncategorized
-
AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024 Posted on by TrueParallel in News&Uncategorized
-
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies Posted on by TrueParallel in News&Uncategorized
-
AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease Posted on by TrueParallel in News&Uncategorized
-
AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial Posted on by TrueParallel in News&Uncategorized
-
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024 Posted on by TrueParallel in News&Uncategorized
